The results from both case studies indicated that the NF-κB pathway would likely be activated, which reflects that our framework can reproduce the already-known fact that the NF-κB pathway is activated in COVID-19, as seen in the KEGG’s COVID-19 pathway (hsa05171). Here, NFKB1 is linked to COVID-19.